Thank you so much for coming. Thank you. I forgot to turn my mike on. Jonathan is a partner with deerfield management and chairman of the deerfield institute. He joined this company in 2013. The company focuses on Venture Capital and structured investments and Bio Technology and pharmaceuticals. Prior to joining deerfield for more than 16 years, jonathan was with Warburg Pincus where he led investment in Bio Technology and pharmaceuticals. Hes been active in policy discussions related to health care and medical innovation and served on the executive committee of the board of the national Venture Capital association and led that groups Life Sciences efforts. He has also served on the emerging Company Section board of the Bio Technology industry organization. He has served on many related nonprofit boards including the reagan ucall foundation for the food and Drug Administration. He is a graduate of Harvard University and the Stanford School of business and we thank you for coming. Thank
One of the things to note on the impact, too, is we are finding that athletes are now failing the impact test on purpose so that their baseline is now lower to start out with. So that if in fact the concussion occurs, they dont have to get back to what truly is their normal baseline. But one that has been fabricated because of choices theyve made during the testtaking. So this is about changing the nature of this injury as well. And really getting people to care about their brains so that they dont make choices like that. And in this case, you mean, that that enables them to get back out on the field. Correct. It takes it takes their baseline and lowers it. So that their results dont have to come back to what is their normal baseline. I see. They wouldnt take that impact until the day after. Correct. Youre doing sort of a quick and dirty on the side lines, to decide whether they can go back in immediately or not. Then you are holding thep out and doing that, you know, check towards bas
Good afternoon and welcome. Im councilman joe pitts. Welcome to the 16th Congressional District of pennsylvania. For your information, this meeting will be streamed live. Cspan is here. So you might want to keep that in mind. But id like to welcome everyone here, especially our distinguished panelists. And i have a short introductory comment to set the stage. Through the 21st century initiative, congress is taking a comprehensive look at the full arc of accelerating cures. From the discovery of clues and basic science, to streamlining the drug and Device Development process, to unleashing the power of medicine and social media the at treatment delivery phase. And this cycle of discovery and development and delivery is what saves lives. And we want this cycle to work effectively and efficiently so theres no gap between the 21st century science and the washington regulatory process. This work will be a collaborative effort which is why we are first listening to experts and involved parti
From our studios in new york city, this is charlie rose. To be blind is not miserable not to be able to bear blindness, that is miserable. John milton wrote that. More than 285 Million People live with visual impairment. For many of these cases, there is no cure. In recent years there have been breakthroughs in our understanding and treatment of blindness. Sanford greenberg lost his vision to glaucoma at the age of 19. He is chairman of the board of governors at Johns Hopkins wilbert eye institute. He joins me to talk about his experience and his mission to end blindness. Plus jean bennett of the university of pennsylvania. Once again, eric kandel, a Howard Hughes medical investigator. I began as i always do with my friend eric to review our subject tonight. The last program we did was a new approach to the treatment of deafness. Tonight we are going to consider new approaches to the treatment of blindness. As is the case with deafness blindness is not a lifethreatening situation, but
From our studios in new york city, this is charlie rose. To be blind is not miserable not to be able to bear blindness, that is miserable. On milton wrote that. More than 285 Million People live with visual impairment. In recent years they have been breakthroughs in our understanding and treatment of blindness. Sanford greenberg lost his vision to ball, at the age of 19. He is chairman of the board of governors at Johns Hopkins wilbert eye institute. He joins me to talk about his experience and his mission to end blindness. Plus jean bennett of the university of pennsylvania. Once again, eric kandel a Howard Hughes medical investigator. I began as i always do with my rent air to review our subject tonight. The last program we did was a new approach to the treatment of deafness. Tonight were going to consider new approaches to the treatment of blindness. As is the case with deafness, blindness is not a lifethreatening situation but in some ways is more disabling as deafness because, as